Market Overview

US Stock Futures Signal Lower Start On Wall Street

US Stock Futures Signal Lower Start On Wall Street
Related PFE
If Gender Confirmation Becomes A Legal Human Right, Which Corporations Could Benefit?
Regeneron's Dupixent Passes The FDA Muster; Baird Sees Strong Lauch
5 Dow Index Stocks That Are Near Buy Points: Investing Action Plan (Investor's Business Daily)
Related MCUR
12 Biggest Mid-Day Gainers For Monday
10 Biggest Mid-Day Losers For Tuesday

Pre-open movers

US stock futures traded lower in early pre-market trade. Futures for the Dow Jones Industrial Average tumbled 95 points to 17,687.00, while the Standard & Poor's 500 index futures fell 11.60 points to 2,041.50. Futures for the Nasdaq 100 index slipped 22.25 points to 4,205.25.

A Peek Into Global Markets

European markets were mostly lower today, with the Spanish Ibex Index dropping 2.04%, STOXX Europe 600 Index declining 0.96% and German DAX 30 index falling 0.54%. French CAC 40 Index declined 0.26% and London's FTSE 100 Index fell 0.18%.

In Asian markets, Japan's Nikkei Stock Average rose 0.36%, Hong Kong's Hang Seng Index fell 0.64%, China's Shanghai Composite Index climbed 0.62% and India's BSE Sensex tumbled 1.71%.

Broker Recommendation
Analysts at BMO Capital upgraded Pfizer (NYSE: PFE) from Market Perform to Outperform and raised the price target from $33.00 to $36.00.

Pfizer's shares rose 0.55% to close at $33.17 on Friday.

Breaking news

  • Macrocure (NASDAQ: MCUR) today announced that Mark Page, a Managing Director at Credit Suisse in New York, will join Macrocure as Chief Financial Officer effective February 10, 2015. To read the full news, click here.
  • Alibaba Group Holding Limited (NYSE: BABA) and Meizu Technology Corporation Limited announced today that Alibaba Group has agreed to invest US$590 million for a minority stake in Meizu, one of China's leading smartphone manufacturers. To read the full news, click here.
  • CASI Pharmaceuticals, Inc. (NASDAQ: CASI) is pleased to announce that it has received formal meeting minutes from the U.S. Food and Drug Administration (FDA) regarding the clinical and regulatory path leading to market approval of ENMD-2076 for the treatment of Fibrolamellar Carcinoma (FLC). To read the full news, click here.
  • FactSet Research Systems Inc. (NYSE: FDS) today announced it has acquired Code Red, Inc. To read the full news, click here.

Posted-In: BMO Capital US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (CASI + BABA)

View Comments and Join the Discussion!